The market for human organs-on-chips was estimated to be worth $115.04 million in 2021, and it is anticipated to increase to $1.20 billion by 2027, with a CAGR of 29.8% during 2022 and 2027.
Organs-on-chip are artificial organs that mimic human organs. It is a multichannel 3D micro-fluidic cell culture apparatus that stimulates the physiological reactions, mechanisms, and activities of organs. A new model of in vitro multicellular human creatures has been developed as a result of the ability of researchers to analyze human physiology in an organ-specific environment using labs-on-chips (LOCs) and cell biology. This chip creates a small passageway for the blood and air to travel through many organs, including the heart, liver, brain, intestines, and lungs. These devices are built on a microchip with constantly perfused chambers populated by living cells and configured to stimulate physiology at the level of the tissues and organs. A silicone-based device called an "organ-on-chip" is utilized to foster internal organs. Tissue engineering and microfluidics are combined to create an innovative technology called organ-on-chip. These technologies are anticipated to offer efficient solutions to persistent problems in drug discovery and targeted illness treatment. It is crucial to medication development investigations, which helps the organ-on-chip market.
The global organ-on-chip market is being driven by an increase in its applications in the healthcare sector, an increase in demand for drug screening, and an increase in demand for lung-based organ culture and kidney applications. The organ-on-chip market is anticipated to experience significant growth in the coming years due to the rise in research activities using organ-on-chip devices as an alternative to animal testing for the discovery of new drugs. The demand for lung- and kidney-based organ culture devices as well as an increase in the demand for organ-on-chips in drug screening are anticipated to drive the market for these products. Additionally, it is anticipated that the lack of donor organs and the availability of functional organs created in a lab will be a huge advantage in meeting the expanding need for organ transplantation.
Nov 17, 2021: AIM Biotech Launches High-throughput Organ-on-a-chip System, The idenTx 40 Plate, to Recreate Human Microphysiology at Scale --
AIM Biotech has launched the idenTx 40 Plate, a high-throughput organ-on-a-chip system that lets researchers at biotechnology and pharmaceutical companies faithfully recreate the function of human organs and tissues without using animals for research. This empowers preclinical studies by delivering human-focused, clinically relevant results to better inform IND candidate selection.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America dominated the worldwide organ-on-chip market in 2020 and is expected to continue to do so during the forecast period. This is attributable to a growth in the use of technologically advanced models, the presence of important players, and an increase in research and development operations for the development of new drugs. However, because to an increase in R&D efforts, an increase in healthcare spending, and diverse tactics among key competitors, the Asia-Pacific region is predicted to have a significant organ-on-chip market opportunity. In addition, according to the prediction for the Asia-Pacific organ-on-chip market, India and China would expand at rapid CAGRs.
The Human Organs-on-Chips Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Human Organs-on-Chips Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 29.8% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory, Altis Biosystems, AxoSim Inc., Bi/ond, BiomimX SRL, Elveflow, Hesperos, Hurel Corporation, Allevi Inc., InSphero AG, Netri |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 102 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Human Organs-on-Chips Market?
The Human Organs-on-Chips Market is growing at a CAGR of 29.8% over the next 5 years.
Who are the key players in Human Organs-on-Chips Market?
Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory, Altis Biosystems, AxoSim Inc., Bi/ond, BiomimX SRL, Elveflow, Hesperos, Hurel Corporation, Allevi Inc., InSphero AG, Netri
What are the significant types of Human Organs-on-Chips Market?
Brain-on-a-chip, Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip, Vessel-on-a-chip, Other Organs
What are the major end-use applications of Human Organs-on-Chips Market?
Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetics Industry, Others
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.